You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 6, 2026

A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
Early splenectomy for chronic myeloid leukemia (CML) does not improve survival or delay disease progression. While operative mortality is low, significant risks of infection and blood clots persist, making it a last resort for advanced cases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: